FilingSEC EDGAR8-K
Rezolute Reports Fiscal 2026 Financial Results and Pipeline Update
· SEC accepted
StagePhase 3
Filing content
Rezolute reported its financial results for the fourth quarter and full fiscal year ended June 30, 2026, and provided an update on the clinical progress of ersodetug.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…